Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med 2008; 359(16):1700–1707.
5 5 Sengupta JN. An overview of esophageal sensory receptors. Am J Med 2000; 108(87S–89S).
6 6 Sleisenger M, Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, and management. 9th ed. Saunders/Elsevier; 2010.
7 7 Knowles CH, Aziz Q. Visceral hypersensitivity in non‐erosive reflux disease. Gut. 2008; 57(5):674–683.
8 8 Orlando RC. Esophageal perception and noncardiac chest pain. Gastroenterol Clin North Am 2004; 33(1):25–33.
9 9 Sengupta JN. Esophageal sensory physiology. GI Motility Online. 2006. https://www.nature.com/gimo/contents/pt1/full/gimo16.html.
10 10 Eslick GD, Talley NJ. Dysphagia: epidemiology, risk factors and impact on quality of life – a population‐based study. Aliment Pharmacol Ther 2008; 27(10):971–979.
11 11 Cho SY, Choung RS, Saito YA, Schleck CD, Zinsmeister AR, Locke GR, 3rd, et al. Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil 2015; 27(2):212–219.
12 12 Sperry SL, Woosley JT, Shaheen NJ, Dellon ES. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol 2012; 107(2):215–221.
13 13 Ahmed M. Eosinophilic esophagitis in adults: An update. World J Gastrointest Pharmacol Ther 2016; 7(2):207–213.
14 14 Cook IJ, Kahrilas PJ. AGA technical review on management of oropharyngeal dysphagia. Gastroenterology. 1999; 116(2):455–478.
15 15 Wilcox CM, Alexander LN, Clark WS. Localization of an obstructing esophageal lesion. Is the patient accurate? Dig Dis Sci 1995; 40(10):2192–2196.
16 16 Spieker MR. Evaluating dysphagia. Am Fam Physician 2000; 61(12):3639–36348.
17 17 Abid S, Mumtaz K, Jafri W, Hamid S, Abbas Z, Shah HA, et al. Pill‐induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005; 37(8):740–744.
18 18 Abdel Jalil AA, Katzka DA, Castell DO. Approach to the patient with dysphagia. Am J Med 2015; 128(10):1138.e17–e23.
19 19 Levine MS, Rubesin SE, Laufer I. Barium esophagography: a study for all seasons. Clin Gastroenterol Hepatol 2008; 6(1):11–25.
20 20 Spechler SJ. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology. 1999; 117(1):233–254.
21 21 Ott DJ, Gelfand DW, Lane TG, Wu WC. Radiologic detection and spectrum of appearances of peptic esophageal strictures. J Clin Gastroenterol 1982; 4(1):11–15.
22 22 Ott DJ, Chen YM, Wu WC, Gelfand DW, Munitz HA. Radiographic and endoscopic sensitivity in detecting lower esophageal mucosal ring. AJR Am J Roentgenol 1986; 147(2):261–265.
23 23 Gallo SH, McClave SA, Makk LJ, Looney SW. Standardization of clinical criteria required for use of the 12.5 millimeter barium tablet in evaluating esophageal lumenal patency. Gastrointest Endosc 1996; 44(2):181–184.
24 24 Richter JE. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol 2007; 4(12):658–664.
25 25 Sutton FM, Graham DY, Goodgame RW. Infectious esophagitis. Gastrointest Endosc Clin N Am 1994;4( 4):713–729.
26 26 Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence‐based consensus. Am J Gastroenterol 2006; 101(8):1900–1920; quiz 43.
27 27 Dent J, Vakil N, Jones R, Bytzer P, Schoning U, Halling K, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010; 59(6):714–721.
28 28 Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional esophageal disorders. Gastroenterology. 2016; 150:1368–1379.
29 29 Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal disorders. Gastroenterology. 2016; 150(6):1380–1392.
30 30 Ford AC, Suares NC, Talley NJ. Meta‐analysis: the epidemiology of noncardiac chest pain in the community. Aliment Pharmacol Ther 2011; 34(2):172–180.
31 31 Eslick GD, Fass R. Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am 2003; 32(2):531–552.
32 32 Hewson EG, Sinclair JW, Dalton CB, Richter JE. Twenty‐four‐hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. Am J Med 1991; 90(5):576–583.
33 33 DeMeester TR, O’Sullivan GC, Bermudez G, Midell AI, Cimochowski GE, O’Drobinak J. Esophageal function in patients with angina‐type chest pain and normal coronary angiograms. Ann Surg 1982; 196(4):488–498.
34 34 Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, et al. Functional esophageal disorders. Gastroenterology. 2006; 130(5):1459–1465.
35 35 Moloy PJ, Charter R. The globus symptom. Incidence, therapeutic response, and age and sex relationships. Ann Surg 1982; 108(11):740–744.
36 36 Wilson JA, Heading RC, Maran AG, Pryde A, Piris J, Allan PL. Globus sensation is not due to gastro‐oesophageal reflux. Clin Otolaryngol Allied Sci 1987; 12(4):271–275.
37 37 Bajbouj M, Becker V, Eckel F, Miehlke S, Pech O, Prinz C, et al. Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology. 2009; 137(2):440–444.
38 38 Kristo I, Rieder E, Paireder M, Schwameis K, Jomrich G, Dolak W, et al. Radiofrequency ablation in patients with large cervical heterotopic gastric mucosa and globus sensation: Closing the treatment gap. Dig Endosc 2018; 30(2):212–218.
39 39 Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med Assoc J 1982; 126(1):46–48.
40 40 Brown SR, Schwartz JM, Summergrad P, Jenike MA. Globus hystericus syndrome responsive to antidepressants. Am J Psychiatry 1986; 143(7):917–918.
41 41 Kiebles JL, Kwiatek MA, Pandolfino JE, Kahrilas PJ, Keefer L. Do patients with globus sensation respond to hypnotically assisted relaxation therapy? A case series report. Dis Esophagus 2010; 23(7):545–553.
42 42 You LQ, Liu J, Jia L, Jiang SM, Wang GQ. Effect of low‐dose amitriptyline on globus pharyngeus and its side effects. World J Gastroenterol 2013; 19(42):7455–7460.
43 43 Kirch S, Gegg R, Johns MM, Rubin AD. Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin. Ann Otol Rhinol Laryngol 2013; 122(8):492–495.
44 44 Havemann BD, Henderson CA, El‐Serag HB. The association between gastro‐oesophageal reflux disease and asthma: a systematic review. Gut. 2007; 56(12):1654–1664.
45 45 Blakey JD, Price DB, Pizzichini E, Popov TA, Dimitrov BD, Postma DS, et al. Identifying risk of future asthma attacks using UK medical record data: a respiratory effectiveness group initiative. J Allergy Clin Immunol Pract 2017; 5(4):1015–1024.e8.
46 46 Chipps BE, Haselkorn T, Paknis B, Ortiz B, Bleecker ER, Kianifard F, et al. More than a decade follow‐up in patients with severe or difficult‐to‐treat asthma: the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) II. J Allergy Clin Immunol 2018; 141(5):1590–1597.e9.
47 47 Almario CV, Ballal ML, Chey WD, Nordstrom C, Khanna D, Spiegel BMR. Burden of gastrointestinal symptoms in the United States: results of a nationally representative survey of over 71,000 Americans. Am J Gastroenterol 2018; 113(11):1701–1710.
48 48 Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019; 156(1):254–272.e11.
49 49 Wahlqvist P, Brook RA, Campbell SM,